Dr. Éva Michaud

Dr. Éva Michaud specializes in immunology and its implications in cancer therapy. She completed her Ph.D. in Immunology from Université Lyon-Saint-Étienne, France, where she investigated the role of secretory IgA in inflammatory bowel diseases (IBD). Dr. Michaud pursued post-doctoral research at McGill University, focusing on immune and microbial determinants of response to radiation therapy in muscle-invasive bladder cancer. Her work explored the interplay between gut microbiome composition and immune responses in bladder cancer, shedding light on potential avenues for improving treatment outcomes. She currently focuses on invesitgating Immunoglobulin A responses in the bladder as a disease biomarker and therapeutic target during bladder cancer, with a specific focus on sex differences in outcomes and immunological responses.